OTC Pharmaceuticals - Mongolia

  • Mongolia
  • Revenue in the OTC Pharmaceuticals market amounts to €49.04m in 2024. The market is expected to grow annually by 4.90% (CAGR 2024-2029).
  • The market's largest segment is the segment Other OTC Pharmaceuticals with a market volume of €18.33m in 2024.
  • In global comparison, most revenue is generated in the United States (€37,850m in 2024).
  • In relation to total population figures, per person revenues of €14.04 are generated in 2024.
  • In the OTC Pharmaceuticals market, 3.2% of total revenue will be generated through online sales by 2024.

Key regions: Worldwide, India, Philippines, United States, Europe

 
Mercado
 
Región
 
Comparación de regiones
 
Moneda
 

Analyst Opinion

The OTC Pharmaceuticals market in Mongolia has been experiencing steady growth in recent years, driven by changing customer preferences, emerging trends in the market, and local special circumstances. Customer preferences in the OTC Pharmaceuticals market have shifted towards self-medication and convenience.

With increasing awareness about health and wellness, consumers are more inclined to take charge of their own healthcare and seek over-the-counter remedies for common ailments. This shift in preference is driven by the convenience of purchasing OTC medications without a prescription, as well as the cost savings associated with not having to visit a doctor for minor health issues. Trends in the market also play a significant role in the development of the OTC Pharmaceuticals market in Mongolia.

One notable trend is the growing demand for natural and herbal remedies. Consumers are increasingly seeking alternative and holistic approaches to healthcare, leading to an increase in the availability and popularity of herbal and natural OTC products. This trend is in line with the global shift towards natural and organic products, reflecting a growing concern for the environment and personal well-being.

Another trend in the OTC Pharmaceuticals market in Mongolia is the rise of e-commerce. The convenience of online shopping has made it easier for consumers to access a wide range of OTC medications from the comfort of their own homes. This trend has been further accelerated by the COVID-19 pandemic, which has led to an increase in online shopping across various industries.

The convenience and safety of online shopping have made it a preferred channel for purchasing OTC medications in Mongolia. Local special circumstances also contribute to the development of the OTC Pharmaceuticals market in Mongolia. The country has a relatively small population and a vast territory, with many rural areas lacking access to healthcare facilities.

This has led to an increased reliance on OTC medications for self-care and minor health issues. Additionally, the high cost of prescription medications and limited availability of healthcare services in some areas further drive the demand for OTC pharmaceuticals. Underlying macroeconomic factors also play a role in the development of the OTC Pharmaceuticals market in Mongolia.

The country has been experiencing steady economic growth, which has led to an increase in disposable income and improved living standards. As a result, consumers are more willing to spend on healthcare products, including OTC medications. Furthermore, the government's efforts to improve healthcare infrastructure and promote self-care have also contributed to the growth of the OTC Pharmaceuticals market.

In conclusion, the OTC Pharmaceuticals market in Mongolia is developing due to changing customer preferences, emerging trends, local special circumstances, and underlying macroeconomic factors. The shift towards self-medication, the demand for natural and herbal remedies, the rise of e-commerce, and the limited access to healthcare facilities in rural areas are all contributing to the growth of the market. Additionally, the country's economic growth and government initiatives are further driving the demand for OTC medications in Mongolia.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

Visión general

  • Revenue
  • Key Players
  • Analyst Opinion
  • Sales Channels
  • Global Comparison
  • Methodology
  • Key Market Indicators
Espere, por favor

Contacto

¿Alguna duda? Estaremos encantados de atenderte.
Statista Locations
Contacto Nerea Marcos
Nerea Marcos
Client Success Manager

Lu - vi, 9:30 - 17:00 h (CET)

Contacto Meredith Alda
Meredith Alda
Sales Manager– Contacto (Estados Unidos)

Lu - vi, 9:00 - 18:00 h (EST)

Contacto Yolanda Mega
Yolanda Mega
Operations Manager– Contacto (Asia)

Lu - vi, 9:00 - 17:00 h (SGT)

Contacto Ayana Mizuno
Ayana Mizuno
Junior Business Development Manager– Contacto (Asia)

Lu - vi, 10:00 - 18:00 h (JST)

Contacto Lodovica Biagi
Lodovica Biagi
Director of Operations– Contacto (Europa)

Lu - vi, 9:30 - 17:00 h (GMT)

Contacto Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contacto (América Latina)

Lu - vi, 9:00am-6:00pm (EST)